Literature DB >> 9024273

Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease.

R A Ajjan1, P F Watson, A P Weetman.   

Abstract

IL-12, IL-13, and IL-15 are important cytokines that have not been studied previously in human autoimmune thyroid diseases. By applying RT-PCR on RNA extracted from tissue samples, we have investigated in vivo gene expression of these cytokines in multinodular goiter (MNG), Graves' disease (GD), and Hashimoto's thyroiditis (HT). In addition, in vitro studies were carried out using the transformed human thyroid cell line, HT-ori3, and primary thyroid cell cultures derived from patients with GD. These cells were used either unstimulated or stimulated for 12 h with TSH, IL-1, or interferon-gamma (IFN-gamma). IL-12 p40 gene expression was identified in 2 of 10 MNG samples, 6 of 12 GD, and 3 of 4 HT. HT-ori3 and primary thyroid cell cultures were positive for IL-12 p40 messenger RNA (mRNA) expression in both unstimulated and stimulated cell cultures. IL-13 mRNA was expressed in 2 MNG, 9 GD, and 1 HT sample. Both HT-ori3 and primary thyroid cultures expressed IL-13 after TSH, IL-1, or IFN-gamma stimulation; unstimulated primary cultures of thyroid cells, however, did not express IL-13. IL-15 gene expression was detected in 8 MNG, 8 GD, and 4 HT samples. HT-ori3 and primary thyroid cell cultures, stimulated with TSH, IL-1, or IFN-gamma, showed expression of this cytokine. Unstimulated cells showed only a weak expression. Our results indicate that the cytokine patterns in the various diseases studied are heterogeneous; that thyroid cells can express IL-12, IL-13, and IL-15 mRNA in culture, particularly after TSH, IL-1, or IFN-gamma stimulation; and that IL-15 is expressed in most of the tissue samples studied.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024273     DOI: 10.1210/jcem.82.2.3760

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system.

Authors:  X X Huang; M Yamashiki; K Nakatani; T Nobori; A Mase
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.

Authors:  Terry J Smith; Dolly A Padovani-Claudio; Ying Lu; Nupur Raychaudhuri; Roshini Fernando; Stephen Atkins; Erin F Gillespie; Andrew G Gianoukakis; Barbra S Miller; Paul G Gauger; Gerard M Doherty; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

3.  Serum levels of interleukin-12 in Graves' disease and their dynamic changes after surgery.

Authors:  Saburo Murakami; Katsuhiko Okubo; Yoshitaka Tsuji; Hideto Sakata; Masataka Kikuchi; Takehiro Takahashi; Takaharu Kato; Renzo Hirayama
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  IL-15 induces alloreactive CD28(-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation.

Authors:  O Traitanon; A Gorbachev; J J Bechtel; K S Keslar; W M Baldwin; E D Poggio; R L Fairchild
Journal:  Am J Transplant       Date:  2014-05-19       Impact factor: 8.086

5.  beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.

Authors:  Krystian Jazdzewski; Tomasz Bednarczuk; Magdalena Stepnowska; Sandya Liyanarachchi; Krystyna Suchecka-Rachon; Janusz Limon; Krzysztof Narkiewicz
Journal:  Int J Mol Med       Date:  2007-01       Impact factor: 4.101

6.  Thyrotropin and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for Pathogenesis of Thyroid-Associated Ophthalmopathy.

Authors:  Tong Wu; Tünde Mester; Shivani Gupta; Fengyuan Sun; Terry J Smith; Raymond S Douglas
Journal:  Thyroid       Date:  2016-10-18       Impact factor: 6.568

7.  Methimazole upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves' disease.

Authors:  T Kocjan; B Wraber; A Kocijancic; S Hojker
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

8.  Genetic copy number alterations and IL-13 expression differences in papillary thyroid cancers and benign nodules.

Authors:  ZeFei Zhao; Qing Wei; Yongju Zhao; Fukang Sun; Xiaolong Jin; Bin Cui; Guang Ning
Journal:  Endocrine       Date:  2009-06-09       Impact factor: 3.633

Review 9.  IL-15: a central regulator of celiac disease immunopathology.

Authors:  Valérie Abadie; Bana Jabri
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

10.  Co-existence of Hashimoto's thyroiditis with familial Mediterranean fever: is there a pathophysiological association between the two diseases?

Authors:  E Gulcan; A Gulcan; M Koplay; A Alcelik; U Korkmaz
Journal:  Clin Exp Immunol       Date:  2009-02-19       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.